Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Longitudinal patterns of STI risk based on psychological characteristics and sexual behavior in heterosexual STI clinic visitors.

van Wees DA, Heijne JCM, Basten M, Heijman T, de Wit J, Kretzschmar MEE, den Daas C.

Sex Transm Dis. 2019 Dec 23. doi: 10.1097/OLQ.0000000000001110. [Epub ahead of print]

PMID:
31876886
2.

Timeliness of infectious disease reporting, the Netherlands, 2003 to 2017: law change reduced reporting delay, disease identification delay is next.

Swaan CM, Wong A, Bonačić Marinović A, Kretzschmar ME, van Steenbergen JE.

Euro Surveill. 2019 Dec;24(49). doi: 10.2807/1560-7917.ES.2019.24.49.1900237.

3.

Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.

Young PW, Zielinski-Gutierrez E, Wamicwe J, Mukui I, Kim AA, Waruru A, Zeh C, Kretzschmar ME, De Cock KM.

AIDS. 2019 Dec 2. doi: 10.1097/QAD.0000000000002453. [Epub ahead of print]

PMID:
31794520
4.

Prediction of human active mobility in rural areas: development and validity tests of three different approaches.

Klous G, Kretzschmar MEE, Coutinho RA, Heederik DJJ, Huss A.

J Expo Sci Environ Epidemiol. 2019 Nov 26. doi: 10.1038/s41370-019-0194-6. [Epub ahead of print]

PMID:
31772295
5.

Who drops out and when? Predictors of non-response and loss to follow-up in a longitudinal cohort study among STI clinic visitors.

van Wees DA, den Daas C, Kretzschmar MEE, Heijne JCM.

PLoS One. 2019 Jun 19;14(6):e0218658. doi: 10.1371/journal.pone.0218658. eCollection 2019.

6.

A Multidimensional Approach to Assessing Infectious Disease Risk: Identifying Risk Classes Based on Psychological Characteristics.

van Wees DA, Heijne JCM, Heijman T, Kampman KCJG, Westra K, de Vries A, de Wit J, Kretzschmar MEE, den Daas C.

Am J Epidemiol. 2019 Sep 1;188(9):1705-1712. doi: 10.1093/aje/kwz140.

7.

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.

van Lier A, de Gier B, McDonald SA, Mangen MJ, van Wijhe M, Sanders EAM, Kretzschmar ME, van Vliet H, de Melker HE.

Euro Surveill. 2019 May;24(18). doi: 10.2807/1560-7917.ES.2019.24.18.1800363.

8.

A stochastic simulation model to study respondent-driven recruitment.

Stein ML, Buskens V, van der Heijden PGM, van Steenbergen JE, Wong A, Bootsma MCJ, Kretzschmar MEE.

PLoS One. 2018 Nov 15;13(11):e0207507. doi: 10.1371/journal.pone.0207507. eCollection 2018.

9.

Study protocol of the iMPaCT project: a longitudinal cohort study assessing psychological determinants, sexual behaviour and chlamydia (re)infections in heterosexual STI clinic visitors.

van Wees DA, Heijne JCM, Heijman T, Kampman KCJG, Westra K, de Vries A, Kretzschmar MEE, den Daas C.

BMC Infect Dis. 2018 Nov 13;18(1):559. doi: 10.1186/s12879-018-3498-6.

10.

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.

Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS, Colomb-Cotinat M, Kretzschmar ME, Devleesschauwer B, Cecchini M, Ouakrim DA, Oliveira TC, Struelens MJ, Suetens C, Monnet DL; Burden of AMR Collaborative Group.

Lancet Infect Dis. 2019 Jan;19(1):56-66. doi: 10.1016/S1473-3099(18)30605-4. Epub 2018 Nov 5.

11.

A systematic knowledge synthesis on the spatial dimensions of Q fever epidemics.

De Rooij MMT, Van Leuken JPG, Swart A, Kretzschmar MEE, Nielen M, De Koeijer AA, Janse I, Wouters IM, Heederik DJJ.

Zoonoses Public Health. 2019 Feb;66(1):14-25. doi: 10.1111/zph.12534. Epub 2018 Nov 6.

PMID:
30402920
12.

The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis.

Teirlinck AC, de Gier B, Meijer A, Donker G, de Lange M, Koppeschaar C, van der Hoek W, Kretzschmar ME, McDonald SA.

Epidemiol Infect. 2018 Oct 23:1-6. doi: 10.1017/S095026881800273X. [Epub ahead of print]

13.

Social networks in relation to self-reported symptomatic infections in individuals aged 40-75 - the Maastricht study.

Brinkhues S, Schram MT, Hoebe CJPA, Kretzschmar MEE, Koster A, Dagnelie PC, Sep SJS, van Kuijk SMJ, Savelkoul PHM, Dukers-Muijrers NHTM.

BMC Infect Dis. 2018 Jul 4;18(1):300. doi: 10.1186/s12879-018-3197-3.

14.

Waning and boosting: on the dynamics of immune status.

Diekmann O, de Graaf WF, Kretzschmar MEE, Teunis PFM.

J Math Biol. 2018 Dec;77(6-7):2023-2048. doi: 10.1007/s00285-018-1239-5. Epub 2018 May 15.

15.

Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.

Cassini A, Colzani E, Pini A, Mangen MJ, Plass D, McDonald SA, Maringhini G, van Lier A, Haagsma JA, Havelaar AH, Kramarz P, Kretzschmar ME, On Behalf Of The BCoDE Consortium.

Euro Surveill. 2018 Apr;23(16). doi: 10.2807/1560-7917.ES.2018.23.16.17-00454.

16.

Double trouble: modelling the impact of low risk perception and high-risk sexual behaviour on chlamydia transmission.

van Wees DA, den Daas C, Kretzschmar MEE, Heijne JCM.

J R Soc Interface. 2018 Apr;15(141). pii: 20170847. doi: 10.1098/rsif.2017.0847.

17.

Pneumonia risk of people living close to goat and poultry farms - Taking GPS derived mobility patterns into account.

Klous G, Smit LAM, Freidl GS, Borlée F, van der Hoek W, IJzermans CJ, Kretzschmar MEE, Heederik DJJ, Coutinho RA, Huss A.

Environ Int. 2018 Jun;115:150-160. doi: 10.1016/j.envint.2018.03.020. Epub 2018 Mar 28.

PMID:
29573654
18.

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.

Horn J, Damm O, Greiner W, Hengel H, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Karch A, Mikolajczyk RT.

BMC Med. 2018 Jan 9;16(1):3. doi: 10.1186/s12916-017-0983-5.

19.

Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics.

Maertens de Noordhout C, Devleesschauwer B, Salomon JA, Turner H, Cassini A, Colzani E, Speybroeck N, Polinder S, Kretzschmar ME, Havelaar AH, Haagsma JA.

Eur J Public Health. 2018 Feb 1;28(1):124-133. doi: 10.1093/eurpub/ckx090.

20.

Development of prediction models for upper and lower respiratory and gastrointestinal tract infections using social network parameters in middle-aged and older persons -The Maastricht Study.

Brinkhues S, van Kuijk SMJ, Hoebe CJPA, Savelkoul PHM, Kretzschmar MEE, Jansen MWJ, de Vries N, Sep SJS, Dagnelie PC, Schaper NC, Verhey FRJ, Bosma H, Maes J, Schram MT, Dukers-Muijrers NHTM.

Epidemiol Infect. 2018 Apr;146(5):533-543. doi: 10.1017/S0950268817002187. Epub 2017 Sep 26.

21.

Cost-effectiveness of human papillomavirus vaccination in Germany.

Damm O, Horn J, Mikolajczyk RT, Kretzschmar MEE, Kaufmann AM, Deleré Y, Ultsch B, Wichmann O, Krämer A, Greiner W.

Cost Eff Resour Alloc. 2017 Sep 4;15:18. doi: 10.1186/s12962-017-0080-9. eCollection 2017.

22.

Mobility assessment of a rural population in the Netherlands using GPS measurements.

Klous G, Smit LAM, Borlée F, Coutinho RA, Kretzschmar MEE, Heederik DJJ, Huss A.

Int J Health Geogr. 2017 Aug 9;16(1):30. doi: 10.1186/s12942-017-0103-y.

23.

Comparing viral load metrics and evaluating their use for HIV surveillance.

Bolijn R, Op de Coul ELM, van Sighem A, Blok WL, Kretzschmar ME, Heijne JCM; ATHENA National Observational HIV Cohort.

J Infect. 2017 Aug;75(2):169-178. doi: 10.1016/j.jinf.2017.05.010. Epub 2017 May 25.

PMID:
28551369
24.

A Software Tool for Estimation of Burden of Infectious Diseases in Europe Using Incidence-Based Disability Adjusted Life Years.

Colzani E, Cassini A, Lewandowski D, Mangen MJ, Plass D, McDonald SA, van Lier A, Haagsma JA, Maringhini G, Pini A, Kramarz P, Kretzschmar ME.

PLoS One. 2017 Jan 20;12(1):e0170662. doi: 10.1371/journal.pone.0170662. eCollection 2017.

25.

Spatial Prediction of Coxiella burnetii Outbreak Exposure via Notified Case Counts in a Dose-Response Model.

Brooke RJ, Kretzschmar ME, Hackert V, Hoebe CJ, Teunis PF, Waller LA.

Epidemiology. 2017 Jan;28(1):127-135.

PMID:
27768623
26.

Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.

Cassini A, Plachouras D, Eckmanns T, Abu Sin M, Blank HP, Ducomble T, Haller S, Harder T, Klingeberg A, Sixtensson M, Velasco E, Weiß B, Kramarz P, Monnet DL, Kretzschmar ME, Suetens C.

PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.

27.

Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.

van Santen DK, de Vos AS, Matser A, Willemse SB, Lindenburg K, Kretzschmar ME, Prins M, de Wit GA.

PLoS One. 2016 Oct 6;11(10):e0163488. doi: 10.1371/journal.pone.0163488. eCollection 2016.

28.

Linking the seroresponse to infection to within-host heterogeneity in antibody production.

Teunis PF, van Eijkeren JC, de Graaf WF, Marinović AB, Kretzschmar ME.

Epidemics. 2016 Sep;16:33-9. doi: 10.1016/j.epidem.2016.04.001. Epub 2016 Apr 28.

29.

Use of a Dose-Response Model to Study Temporal Trends in Spatial Exposure to Coxiella burnetii: Analysis of a Multiyear Outbreak of Q Fever.

Brooke RJ, Teunis PF, Kretzschmar ME, Wielders CC, Schneeberger PM, Waller LA.

Zoonoses Public Health. 2017 Mar;64(2):118-126. doi: 10.1111/zph.12288. Epub 2016 Aug 23.

PMID:
27549241
30.

Impact of Heterogeneity in Sexual Behavior on Effectiveness in Reducing HIV Transmission with Test-and-Treat Strategy.

Rozhnova G, van der Loeff MF, Heijne JC, Kretzschmar ME.

PLoS Comput Biol. 2016 Aug 1;12(8):e1005012. doi: 10.1371/journal.pcbi.1005012. eCollection 2016 Aug.

31.

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.

van Lier A, McDonald SA, Bouwknegt M; EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE.

PLoS One. 2016 Apr 20;11(4):e0153106. doi: 10.1371/journal.pone.0153106. eCollection 2016.

32.

Modelling the risk of transfusion transmission from travelling donors.

Mapako T, Oei W, van Hulst M, Kretzschmar ME, Janssen MP.

BMC Infect Dis. 2016 Apr 1;16:143. doi: 10.1186/s12879-016-1452-z.

33.

Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.

Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, Mikolajczyk RT.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1766-76. doi: 10.1080/21645515.2015.1135279. Epub 2016 Feb 2.

34.

Assessing disability weights based on the responses of 30,660 people from four European countries.

Haagsma JA, Maertens de Noordhout C, Polinder S, Vos T, Havelaar AH, Cassini A, Devleesschauwer B, Kretzschmar ME, Speybroeck N, Salomon JA.

Popul Health Metr. 2015 Apr 3;13:10. doi: 10.1186/s12963-015-0042-4. eCollection 2015.

35.

Estimating the risk of dengue transmission from Dutch blood donors travelling to Suriname and the Dutch Caribbean.

Oei W, Lieshout-Krikke RW, Kretzschmar ME, Zaaijer HL, Coutinho RA, Eersel M, Jubithana B, Halabi Y, Gerstenbluth I, Maduro E, Tromp M, Janssen MP.

Vox Sang. 2016 May;110(4):301-9. doi: 10.1111/vox.12370. Epub 2016 Jan 14.

PMID:
26765798
36.

Burden of four vaccine preventable diseases in older adults.

Kristensen M, van Lier A, Eilers R, McDonald SA, Opstelten W, van der Maas N, van der Hoek W, Kretzschmar ME, Nielen MM, de Melker HE.

Vaccine. 2016 Feb 10;34(7):942-9. doi: 10.1016/j.vaccine.2015.12.052. Epub 2016 Jan 3.

PMID:
26752065
37.

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005-2011.

McDonald SA, Teunis P, van der Maas N, de Greeff S, de Melker H, Kretzschmar ME.

BMC Infect Dis. 2015 Dec 29;15:588. doi: 10.1186/s12879-015-1324-y.

38.

Tracking social contact networks with online respondent-driven detection: who recruits whom?

Stein ML, van der Heijden PG, Buskens V, van Steenbergen JE, Bengtsson L, Koppeschaar CE, Thorson A, Kretzschmar ME.

BMC Infect Dis. 2015 Nov 14;15:522. doi: 10.1186/s12879-015-1250-z.

39.

To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable.

Bijkerk P, Fanoy EB, Kardamanidis K, van der Plas SM, Te Wierik MJ, Kretzschmar ME, Haringhuizen GB, van Vliet HJ, van der Sande MA.

Euro Surveill. 2015;20(34):30003. doi: 10.2807/1560-7917.ES.2015.20.34.30003.

40.

Enhancing Syndromic Surveillance With Online Respondent-Driven Detection.

Stein ML, van Steenbergen JE, Buskens V, van der Heijden PG, Koppeschaar CE, Bengtsson L, Thorson A, Kretzschmar ME.

Am J Public Health. 2015 Aug;105(8):e90-7. doi: 10.2105/AJPH.2015.302717. Epub 2015 Jun 11.

41.

Exposure to low doses of Coxiella burnetii caused high illness attack rates: Insights from combining human challenge and outbreak data.

Brooke RJ, Mutters NT, Péter O, Kretzschmar ME, Teunis PF.

Epidemics. 2015 Jun;11:1-6. doi: 10.1016/j.epidem.2014.12.004. Epub 2014 Dec 31.

42.

Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands.

de Wit GA, Over EA, Schmid BV, van Bergen JE, van den Broek IV, van der Sande MA, Welte R, Op de Coul EL, Kretzschmar ME.

Sex Transm Infect. 2015 Sep;91(6):423-9. doi: 10.1136/sextrans-2014-051677. Epub 2015 Mar 10.

PMID:
25759475
43.

Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?

de Vos AS, Prins M, Kretzschmar ME.

Addiction. 2015 Jun;110(6):975-83. doi: 10.1111/add.12842. Epub 2015 Feb 8.

PMID:
25586171
44.

Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review.

Oostvogels AJ, De Wit GA, Jahn B, Cassini A, Colzani E, De Waure C, Kretzschmar ME, Siebert U, Mühlberger N, Mangen MJ.

Epidemiol Infect. 2015 Jul;143(9):1791-802. doi: 10.1017/S0950268814001940. Epub 2014 Dec 12. Review.

45.

A two-phase within-host model for immune response and its application to serological profiles of pertussis.

de Graaf WF, Kretzschmar ME, Teunis PF, Diekmann O.

Epidemics. 2014 Dec;9:1-7. doi: 10.1016/j.epidem.2014.08.002. Epub 2014 Aug 26.

46.

Comparison of contact patterns relevant for transmission of respiratory pathogens in Thailand and The Netherlands using respondent-driven sampling.

Stein ML, van Steenbergen JE, Buskens V, van der Heijden PG, Chanyasanha C, Tipayamongkholgul M, Thorson AE, Bengtsson L, Lu X, Kretzschmar ME.

PLoS One. 2014 Nov 25;9(11):e113711. doi: 10.1371/journal.pone.0113711. eCollection 2014.

47.

Impact of early-stage HIV transmission on treatment as prevention.

Powers KA, Kretzschmar ME, Miller WC, Cohen MS.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):15867-8. doi: 10.1073/pnas.1418496111. Epub 2014 Nov 3. No abstract available.

48.

Benefits of hepatitis C virus treatment: a balance of preventing onward transmission and re-infection.

de Vos AS, Kretzschmar ME.

Math Biosci. 2014 Dec;258:11-8. doi: 10.1016/j.mbs.2014.09.006. Epub 2014 Sep 19.

PMID:
25242609
49.

Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.

van Santen DK, van der Helm JJ, Grady BP, de Vos AS, Kretzschmar ME, Stolte IG, Prins M.

AIDS. 2014 Nov 13;28(17):2589-99. doi: 10.1097/QAD.0000000000000450.

PMID:
25211439
50.

[Syndromic surveillance: a finger on the pulse of public health].

van Asten L, Fanoy EB, Hooiveld M, Koopmans MP, Kretzschmar ME; Werkgroep inventarisatie syndroomsurveillance.

Ned Tijdschr Geneeskd. 2014;158:A7415. Review. Dutch.

PMID:
24975977

Supplemental Content

Loading ...
Support Center